SONN logo

SONN Stock Overview

Profile

Full Name:

Sonnet BioTherapeutics Holdings, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

October 31, 2006

Indexes:

Not included

Website:

http://www.sonnetbio.com

Description:

Sonnet BioTherapeutics Holdings is a biotechnology company focused on developing innovative therapies for cancer and other diseases. They use a unique platform to create targeted treatments that aim to improve patient outcomes and reduce side effects, making healthcare more effective and accessible.

Key Details

Price

$1.59

Market Cap

$4.87 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$18.60 K(-87.42% YoY)

Annual EPS

-$11.35(+92.18% YoY)

PE Ratio

-

Annual ROE

1531.23%

Annual Debt To Equity

0.00

Beta

0.14

Events Calendar

Earnings

Next earnings date:

May 14, 2025

Recent quarterly earnings:

Feb 13, 2025

Recent annual earnings:

Dec 17, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sep 30, 2024

Analyst ratings

Recent major analysts updates

Dec 20, 24 Chardan Capital
Buy
Aug 23, 24 Chardan Capital
Buy
May 28, 24 Chardan Capital
Buy
May 16, 24 EF Hutton
Buy
Feb 15, 24 Chardan Capital
Buy
Nov 27, 23 Ladenburg Thalmann
Buy
Aug 16, 23 Chardan Capital
Buy
Jun 26, 23 EF Hutton
Buy
May 11, 23 Chardan Capital
Buy
Apr 19, 23 EF Hutton
Buy

Screeners with SONN included

Growing Shares Outstanding
US stocks
Stocks below SMA 200
Most recommended stocks
Stocks below analysts price target
Healthcare sector
All stocks
Biggest stock gainers today
Biotechnology industry
Small cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.59
SONN price is $1.59

Price All-time High

$8008000.00
SONN price is currently -100.00% below its historical high of $8008000.00

Price Analysts Target

$160.00
SONN price is currently -99.01% lower than the consensus analysts' forecast

Price Most Recent Change

+15.14%
SONN price was up +15.14% on Feb 24, 2025

Price YTD Change

+9.48%
SONN price is up +9.48% since January 1st

Price 3-Year Change

-99.77%
SONN price is down -99.77% over the past 3 years

Market cap

Market Cap

$4.87 M
SONN market capitalization is $4.87 million

Market Cap 3-Year Change

-71.18%
SONN market capitalization is down -71.18% over the past 3 years

Market Cap All-time High

$588.65 M
SONN market capitalization is currently -99.17% below its historical high of $588.65 million

Market Cap Sector Rank

12.2%
SONN market capitalization is higher than 12.2% of companies in Healthcare sector

Technical

Beta

0.14
SONN beta is 0.14

200-day SMA

$5.82
SONN price is currently -72.70% below its 200-day simple moving average

14-day RSI

42.75
SONN 14-day relative strength index is 42.75

30-day Relative Volume

0.74
SONN 30-day relative volume is 0.74

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$18.60 K
SONN annual revenue is $18.60 thousand

Annual Revenue Analysts Estimate

-
SONN annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-87.42%
SONN annual revenue is down -87.42% year-on-year

Annual Revenue Sector Rank

2.68%
SONN annual revenue is higher than 2.68% of companies in Healthcare sector

Profit

Annual Gross Profit

-
SONN annual gross profit value is unknown

Annual Gross Margin

-
SONN annual gross profit margin value is unknown

Annual Operating Profit

-$11.85 M
SONN annual operating income is -$11.85 million

Annual Operating Margin

-63.62 K%
SONN annual operating profit margin is -63.62 thousand%

Annual Net Income

-$7.44 M
SONN annual net profit is -$7.44 million

Annual Net Margin

-39.93 K%
SONN annual net profit margin is -39.93 thousand%

EPS

Annual EPS

-$11.35
SONN annual earnings per share is -$11.35

Annual EPS Analysts Estimate

-$27.36
SONN annual earnings per share is currently -58.52% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+92.18%
SONN annual earnings per share is up +92.18% year-on-year

Annual EPS Sector Rank

14.02%
SONN annual earnings per share is higher than 14.02% of companies in Healthcare sector

ROA & ROE

Annual ROA

-181.38%
SONN annual return on assets is -181.38%

Annual ROE

1531.23%
SONN annual return on equity is 1531.23%

EBIT & EBITDA

Annual EBIT

-$11.85 M
SONN annual earnings before interest & taxes is -$11.85 million

Annual EBITDA

-$11.77 M
SONN annual EBITDA is -$11.77 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
SONN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
SONN price to earnings ratio is unknown

PB Ratio

PB Ratio

1.21
SONN price to book ratio is 1.21

PB Ratio Sector Rank

46.23%
SONN price to book ratio is higher than 46.23% of companies in Healthcare sector

PS Ratio

PS Ratio

4.87
SONN price to sales ratio is 4.87

PS Ratio Sector Rank

62.21%
SONN price to sales ratio is higher than 62.21% of companies in Healthcare sector

Enterprise value

Enterprise Value

$120.80 K
SONN enterprise value is $120.80 thousand

Enterprise Value Sector Rank

10.87%
SONN enterprise value is higher than 10.87% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.01
SONN EV/EBITDA is -0.01

EV/EBITDA Sector Rank

67.25%
SONN EV/EBITDA is higher than 67.25% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.66
SONN annual current ratio is 0.66

Annual Quick Ratio

-
SONN annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
SONN annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
SONN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SONN piotroski f-score value is unknown

Altman Z-Score

-73.14
SONN altman z-score is -73.14

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$2.77 M
SONN annual total assets is $2.77 million

Annual Non Current Assets

$653.10 K
SONN annual long term assets is $653.10 thousand

Annual Current Assets

$2.12 M
SONN annual total current assets is $2.12 million

Annual Cash & Cash Equivalents

$149.50 K
SONN annual cash & cash equivalents is $149.50 thousand

Equity

Annual Book Value

-$485.70 K
SONN annual book value is -$485.70 thousand

Annual Working Capital

-$1.09 M
SONN annual working capital is -$1.09 million

Liabilities

Annual Total Liabilities

$3.26 M
SONN annual total liabilities is $3.26 million

Annual Total Long Term Liabilities

$46.60 K
SONN annual total long term liabilities is $46.60 thousand

Annual Current Liabilities

$3.21 M
SONN annual total current liabilities is $3.21 million

Annual Accounts Payable

$2.18 M
SONN annual accounts payable is $2.18 million

Debt

Annual Total Debt

$130.90 K
SONN annual total debt is $130.90 thousand

Annual Total Debt 1-Year Change

-35.8%
SONN annual total debt is down -35.8% year-on-year

Annual Long Term Debt

$46.60 K
SONN annual long term debt is $46.60 thousand

Annual Short Term Debt

$84.30 K
SONN annual short term debt is $84.30 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$11.87 M
SONN annual total expenses is $11.87 million

Annual Operating Expenses

$11.87 M
SONN annual total operating expenses is $11.87 million

Annual Cost Of Goods Sold

-
SONN annual cost of goods sold value is unknown

Annual SGA

$6.13 M
SONN annual SGA is $6.13 million

Annual D&A

$83.10 K
SONN annual depreciation & amortization is $83.10 thousand

Annual Interest Expense

-
SONN annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$8.61 M
SONN annual cash flow from operations is -$8.61 million

Annual CFO 1-Year Change

+59.67%
SONN annual cash flow from operations is up +59.67% year-on-year

Annual CFI

-$12.00 K
SONN annual cash flow from investing activities is -$12.00 thousand

Annual CFI 1-Year Change

+97.29%
SONN annual cash flow from investing activities is up +97.29% year-on-year

Annual CFF

$6.49 M
SONN annual cash flow from financing activities is $6.49 million

Annual CFF 1-Year Change

-69.08%
SONN annual cash flow from financing activities is down -69.08% year-on-year

Free CashFlow

Annual FCF

-$8.62 M
SONN annual free cash flow is -$8.62 million

Annual FCF 1-Year Change

+60.43%
SONN annual free cash flow is up +60.43% year-on-year

CAPEX

Annual CAPEX

$12.00 K
SONN annual capital expenditures is $12.00 thousand

Annual CAPEX 1-Year Change

-97.29%
SONN annual capital expenditures is down -97.29% year-on-year

Institutional Ownership

Similar stocks

PBM logo
Psyence Biomedical (PBM)
PRTG logo
Portage Biotech (PRTG)
CERO logo
CERo Therapeutics Holdings (CERO)
ALZN logo
Alzamend Neuro (ALZN)
ACON logo
Aclarion (ACON)
SPRC logo
SciSparc (SPRC)
RNAZ logo
TransCode Therapeutics (RNAZ)
ADIL logo
Adial Pharmaceuticals (ADIL)
TIVC logo
Tivic Health Systems (TIVC)

FAQ

  • What is the ticker symbol for Sonnet BioTherapeutics Holdings?
  • Does Sonnet BioTherapeutics Holdings pay dividends?
  • What sector is Sonnet BioTherapeutics Holdings in?
  • What industry is Sonnet BioTherapeutics Holdings in?
  • What country is Sonnet BioTherapeutics Holdings based in?
  • When did Sonnet BioTherapeutics Holdings go public?
  • Is Sonnet BioTherapeutics Holdings in the S&P 500?
  • Is Sonnet BioTherapeutics Holdings in the NASDAQ 100?
  • Is Sonnet BioTherapeutics Holdings in the Dow Jones?
  • When was Sonnet BioTherapeutics Holdings's last earnings report?
  • When does Sonnet BioTherapeutics Holdings report earnings?
  • Should I buy Sonnet BioTherapeutics Holdings stock now?

What is the ticker symbol for Sonnet BioTherapeutics Holdings?

The ticker symbol for Sonnet BioTherapeutics Holdings is NASDAQ:SONN

Does Sonnet BioTherapeutics Holdings pay dividends?

No, Sonnet BioTherapeutics Holdings does not pay dividends

What sector is Sonnet BioTherapeutics Holdings in?

Sonnet BioTherapeutics Holdings is in the Healthcare sector

What industry is Sonnet BioTherapeutics Holdings in?

Sonnet BioTherapeutics Holdings is in the Biotechnology industry

What country is Sonnet BioTherapeutics Holdings based in?

Sonnet BioTherapeutics Holdings is headquartered in United States

When did Sonnet BioTherapeutics Holdings go public?

Sonnet BioTherapeutics Holdings's initial public offering (IPO) was on October 31, 2006

Is Sonnet BioTherapeutics Holdings in the S&P 500?

No, Sonnet BioTherapeutics Holdings is not included in the S&P 500 index

Is Sonnet BioTherapeutics Holdings in the NASDAQ 100?

No, Sonnet BioTherapeutics Holdings is not included in the NASDAQ 100 index

Is Sonnet BioTherapeutics Holdings in the Dow Jones?

No, Sonnet BioTherapeutics Holdings is not included in the Dow Jones index

When was Sonnet BioTherapeutics Holdings's last earnings report?

Sonnet BioTherapeutics Holdings's most recent earnings report was on Feb 13, 2025

When does Sonnet BioTherapeutics Holdings report earnings?

The next expected earnings date for Sonnet BioTherapeutics Holdings is May 14, 2025

Should I buy Sonnet BioTherapeutics Holdings stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions